Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Ad/Promo: Improved Adherence Claim For Dexcel’s Hemady Not Supported, US FDA Says
Mar 04 2025
•
By
Sue Sutter
The FDA dug deep into the design and methodology of the study for the Hemady adherence claim.
(Shutterstock)
More from Marketing & Advertising
More from R&D